Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
Catalyst MedTech, a national leader in nuclear medicine and molecular imaging solutions, today announced the continued ...
PET tracer ACI-19626 safely detects toxic TDP-43 protein clumps in the brain. TDP-43 clumps are a hallmark in 97% of ALS ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) on Wednesday announced “NovaScan Neuroimaging Clinics” as the new brand name ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) earlier this week outlined plans to expand into nuclear medicine with the launch of a network of specialized brain imaging clinics across the United ...
Phase 2b data show RAD101 amino acid PET hits 90% concordance, helping distinguish brain metastasis recurrence from ...
Researchers at UC San Francisco have discovered how exercise may help protect the brain and reduce the risk of Alzheimer’s ...
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key ...
GlobalData on MSN
Neurophet and ALZ-NET sign MoU on Alzheimer’s therapies
The collaboration targets increased awareness of amyloid-related imaging abnormalities monitoring.
My biggest goal is to help other people because what happened to me was so out of the blue and so terrifying,” Tori Carmen ...
Catalyst MedTech, a national leader in nuclear medicine and molecular imaging solutions, today announced the continued national deployment of its Full Access Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results